NTx is redefining the discovery and production of biologic materials to be infinitely faster, purer and more affordable for everyone with breakthrough advances in cell-free (CF) biomanufacturing. We’re moving beyond empowering biopharma to impact global health and humanity.
While cell-free manufacturing was established decades ago, our platforms are scalable to rapidly support clinical trials and ultimately to fuel global supply chains. We help researchers innovate faster and we are committed to helping companies increase and streamline production as they respond to changing global demand.
While cell-free manufacturing was established decades ago, our platforms are scalable to rapidly support clinical trials and ultimately to fuel global supply chains. We help researchers innovate faster and we are committed to helping companies increase and streamline production as they respond to changing global demand.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
New Mexico
Company HQ Country:
United States
Year Founded:
2015
Main Therapeutic Focus:
Lead Product in Development:
NTxscribe (mRNA manufacturing platform)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
